All investors
General Catalyst

General Catalyst

Visit website

General Catalyst is a global investment and transformation firm that backs ambitious founders building enduring, category-defining companies across critical sectors. The firm combines seed-to-growth investing with company creation, transformation platforms, and long-horizon capital, with a strong emphasis on applied AI, resilience, responsible innovation, and collaboration with incumbent institutions.

Evaluation weights

How much weight this investor places on each dimension. Totals 100%.

Team-led · 37%
Metrics
8%

Revenue, growth, and unit economics

Market
32%

Size, timing, and competitive landscape

Team
37%

Founder experience and execution ability

Product
23%

Differentiation and technical quality

  • Biased toward exceptional founders over perfect early metrics
  • Prefers consequential sectors where outcomes matter more than consumer-style growth optics
  • Favors collaboration with incumbents over disruption theater in regulated markets
  • Willing to underwrite complexity and long time horizons when the company can define a category

Pitch difficulty

How hard it is to get a meeting and close funding from this investor.

Funded / yr
33

Deals closed in a typical year.

Led / yr
103

Rounds led in the last 12 months.

Pitches / yr
~3500

Decks reviewed in a typical year.

Acceptance rate
0.94%

Share of pitches that get funded.

Estimated — public data is not fully disclosed.

Why it's hard
  • Looks for exceptional, ambiguity-tolerant founders rather than merely solid operators
  • Concentrates on category-defining opportunities in large, strategic markets
  • Has a strong filter around responsible innovation and regulated-market credibility
  • Often leads major rounds, implying a high-conviction underwriting standard

General Catalyst is highly selective because it invests behind strong conviction in founders and markets with the potential for category-defining, system-level impact. Its broad stage range and large check capacity are offset by a high bar around founder quality, responsible innovation, institutional collaboration, and the ability to build enduring companies in critical sectors.

Green flags

What drives a yes for this investor.

  • Exceptional founders who can operate through ambiguity and build category leaders
  • A credible path to durable, system-level impact rather than point-solution novelty
  • Alignment with responsible innovation, especially in healthcare, defense, and other regulated domains
  • Ability to collaborate with incumbents and align incentives instead of pursuing naive disruption
  • Evidence the company can become enduring infrastructure or a market-defining platform

Red flags

What kills deals and gets a fast no.

  • A disruption narrative that ignores the realities of healthcare, defense, finance, or other regulated systems
  • Weak or non-credible founder-market fit for a complex, high-stakes category
  • AI or automation positioning without meaningful technical edge or real customer outcomes
  • Pilot traction without evidence of scaled adoption or durable embedment
  • Misalignment with responsible innovation or lack of trustworthiness in sensitive domains

How to win

Patterns that lead to successful pitches.

  • Frame the company as an enduring platform with system-level importance, not a tactical point solution
  • Show why this founding team is uniquely equipped to navigate complexity, regulation, and institutional adoption
  • Demonstrate measurable customer outcomes and deep workflow importance, especially in critical sectors
  • Present a collaboration strategy with incumbents and ecosystem partners rather than a pure displacement story
  • Tie the opportunity to resilience, applied AI, or transformation in a large market undergoing structural change

Fund strategy & identity

Who they are and how they operate.

  • Invests from Seed through Growth, often leading or co-leading when conviction is high
  • Uses multiple models: Ignition for early stage, Endurance for growth, and Creation for company hatching
  • Leans into applied AI, critical infrastructure, and regulated-market transformation
  • Supports M&A-enabled and vertically integrated strategies when they accelerate system change
  • Pairs investing with platform-driven transformation efforts such as Health Assurance and Percepta
Firm identity
Founder-centric and conviction-led Transformation-oriented, not just financial capital Long-duration partner through ambiguity and pivots Responsible-innovation focused in regulated sectors Global platform spanning the US, Europe, and India

Investment focus

Industries, themes, and typical ARR expectations.

Industries
Artificial IntelligenceHealthcareFintechDefense & IntelligenceIndustrial IoTClimate & EnergyConsumer Marketplaces
Investment themes
Applied AI infrastructure, intelligence, and workforce enablementHealth Assurance and value-based healthcare transformationDefense, intelligence, and mission-critical resilience technologiesFintech and foundational financial infrastructureIndustrial IoT and real-world operational softwareAI-enabled services and automation platformsConsumer and marketplace platforms with durable network effects
Typical check by stage
Pre Seed$0.25M-$2M
Seed$0.5M-$5M (up to ~$10M when leading)
Series A$10M-$30M
Series B$20M-$75M+
Series C$30M-$150M
Growth$50M-$200M+
Typical ARR by stage
Seed$0-$1M
Series A$1M-$5M
Series B$5M-$20M
Series C$20M-$50M
Growth$50M-$100M+

Investment thesis

Core beliefs and strategy behind their investing approach.

General Catalyst positions itself as an investment and transformation firm that backs ambitious founders to drive resilience, responsible innovation, and applied AI across critical sectors. Its thesis centers on three operating models: Creation (co‑founding and hatching companies in underserved markets), Ignition (seed and early‑stage investing with hands‑on support), and Endurance (late‑stage growth and public‑market preparation). Two transformation platforms extend this framework: Health Assurance (via HATCo) to build affordable, proactive healthcare systems, and Percepta to accelerate enterprise AI adoption. The firm focuses on fintech, digital health, AI‑enabled services, industrial IoT, defense & intelligence, climate & energy, and consumer marketplaces, with a geographic footprint in the United States, Europe, and India supported by offices in San Francisco, New York, London, Berlin, and Bengaluru. General Catalyst avoids pure cost‑cutting, extractive PE‑style roll‑ups and "disruption for disruption's sake" in regulated domains, preferring long‑duration capital, aligned incentives, and outcomes‑based business models. Core belief: value is created by building enduring, market‑leading companies that generate both financial returns and positive societal impact.

Decision patterns

How they evaluate and make investment decisions.

General Catalyst is conviction‑led and founder‑centric at the earliest stages: "back exceptional people early," thrive in ambiguity, and act as a consistent, non‑fair‑weather partner through pivots and messy middle phases. They emphasize radical collaboration with existing institutions (e.g., hospitals, defense primes) and responsible innovation. In healthcare, they avoid a "disrupt and replace" mindset, instead aligning incentives around value‑based care and operating on multi‑decade horizons (HATCo). In applied AI, they prioritize category‑defining companies that harness intelligence, infrastructure, and workforce enablement, having invested billions since 2017 to back top technical talent. GC often leads or co‑leads when conviction is high (e.g., Helsing Series B) and may deploy creation strategies or M&A‑enabled roll‑ups when vertical integration accelerates transformation. Deal‑breakers include misalignment with responsible innovation, inability to collaborate with incumbents in regulated markets, or lack of a credible path to durable system‑level impact.

Risk appetite

General Catalyst displays an assertive, long‑term risk posture. It frequently leads or co‑leads large rounds, backing founders early and staying hands‑on through ambiguity. The firm is comfortable underwriting technology, go‑to‑market, and regulatory adoption risk when it aligns with their resilience and applied‑AI theses, but it tempers this aggressiveness with a focus on responsible innovation and deep collaboration with incumbents.

Notable investments

Key portfolio companies and why they fit the thesis.

  • HelsingLead
    Defense AI startup aligns with GC’s global resilience and applied‑AI thesis.
  • PantomathLead
    AI‑driven data‑reliability platform fits GC’s applied‑AI and automation focus.
  • FabricLead
    Health‑care care‑enablement platform matches GC’s Health Assurance vision.
  • Soda HealthLead
    Smart benefits operating system advances health equity, a core Health Assurance theme.
  • CampusLead
    Education‑upskilling model supports societal resilience and talent pipeline.
  • ClarosLead
    Energy‑efficiency solution for AI data‑centers complements GC’s resilience and industrial thesis.
  • Mission Control GamesLead
    AI‑enhanced casual gaming illustrates GC’s interest in applied‑AI consumer experiences.
  • BolnaLead
    India‑focused voice‑AI platform expands GC’s applied‑AI reach into emerging markets.
  • AgentMailLead
    Infrastructure for AI agents aligns with GC’s applied‑AI and platform strategy.
  • Stripe
    Fintech infrastructure underpins the resilient digital economy GC invests in.

Key people

Partners who lead investments and shape the thesis.

  • HT
    Hemant Taneja
    CEO & Managing Director
    AIHealthcareDefense & GovernmentIndustrialsEnergyFintechConsumerEnterprise
  • Jz
    Jeannette zu Fürstenberg
    President & Managing Director
    Seed/Early-stageIndustrial & Enterprise networks in EuropeApplied AI
  • JC
    Joel Cutler
    Co-Founder & Managing Director
    ConsumerEnterpriseCompany creation
  • CB
    Chris Bischoff
    Managing Director, Head of Health Assurance & Co-Head of Europe
    HealthcareEurope
  • HM
    Holly Maloney
    Managing Director
    HealthcareEnterprise

Public voice

Notable statements and public positions.

  • Customers care about outcomes, not products.
  • HATCo’s charter is not to disrupt healthcare systems; rather, it is to be in service of healthcare organizations everywhere…
  • We have the audacity to believe we can build enduring, market leading companies on the right side of history.